| Year |
Citation |
Score |
| 2020 |
Meyer L, Verbist KC, Albeituni S, Scull BP, Bassett R, Stroh AN, Tillman H, Allen CE, Hermiston M, Nichols KE. JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood. PMID 32530039 DOI: 10.1182/Blood.2020006075 |
0.359 |
|
| 2020 |
Rodriguez-Galindo C, Allen CE. Langerhans Cell histiocytosis. Blood. PMID 32106306 DOI: 10.1182/Blood.2019000934 |
0.361 |
|
| 2020 |
Lim KPH, Milne P, Poidinger M, Duan K, Lin H, McGovern N, Abhyankar H, Zinn D, Burke TM, Eckstein OS, Chakraborty R, Sengal A, Scull B, Newell E, Merad M, ... ... Allen CE, et al. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells. Blood Advances. 4: 87-99. PMID 31899802 DOI: 10.1182/Bloodadvances.2019000488 |
0.31 |
|
| 2020 |
Martinez C, Aguayo-Hiraldo PI, Rider NI, Nicholas SK, Forbes L, Seeborg FO, Noroski LM, Omer B, John T, Yassine K, Doherty EE, Steffin DH, Naik S, Craddock J, Allen C, et al. Excellent Engraftment with Reduced Treatment Related Mortality for Young Pediatric Patients Using Umbilical Cord Blood Transplantation (UCBT) Conditioned without Serotherapy Biology of Blood and Marrow Transplantation. 26: S289. DOI: 10.1016/J.Bbmt.2019.12.561 |
0.321 |
|
| 2020 |
Klinger J, Aguayo-Hiraldo P, Rider NI, Nicholas SK, Forbes L, Seeborg FO, Noroski LM, Omer B, John T, Yassine K, Naik S, Craddock J, Steffin DH, Doherty EE, Allen C, et al. Reduced Autoimmune Cytopenias after Cord Blood Transplant in Pediatric Patients with Nonmalignant Disease Conditioned without Serotherapy Biology of Blood and Marrow Transplantation. 26: S214. DOI: 10.1016/J.Bbmt.2019.12.528 |
0.312 |
|
| 2019 |
Allen CE, Beverley PCL, Collin M, Diamond EL, Egeler RM, Ginhoux F, Glass C, Minkov M, Rollins BJ, van Halteren A. The coming of age of Langerhans cell histiocytosis. Nature Immunology. PMID 31831887 DOI: 10.1038/S41590-019-0558-Z |
0.313 |
|
| 2019 |
Naik S, Martinez CA, Omer B, Sasa G, Yassine K, Allen CE, Kamdar K, Orth R, Wu M, Leung K, Gottschalk S, Brenner MK, Heslop HE, Krance RA. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients. Blood Advances. 3: 2689-2695. PMID 31511228 DOI: 10.1182/Bloodadvances.2018026203 |
0.321 |
|
| 2019 |
Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A, Hines M, Eckstein O, Ladisch S, Nichols KE, Rodriguez-Galindo C, Wistinghausen B, McClain KL. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatric Blood & Cancer. e27929. PMID 31339233 DOI: 10.1002/Pbc.27929 |
0.307 |
|
| 2019 |
Eckstein OS, Visser J, Rodriguez-Galindo C, Allen CE. Clinical responses and persistent BRAF+ blood cells in children with LCH treated with MAPK pathway inhibition. Blood. PMID 30718231 DOI: 10.1182/Blood-2018-10-878363 |
0.339 |
|
| 2019 |
Naik S, Eckstein OS, Sasa G, Krance RA, Allen CE, Heslop HE, Martinez CA. Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphohistiocytosis Blood. 134: 3273-3273. DOI: 10.1182/Blood-2019-132120 |
0.304 |
|
| 2019 |
Eckstein OS, Gulati N, Forbes L, Peckham-Gregory E, Ozuah NW, Poli MC, Vogel T, Mace EM, Orange JS, Caldwell J, Jolles S, Saettini F, Chong HJ, Stray-Pedersen A, Heslop HE, ... ... Allen CE, et al. Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders Blood. 134: 83-83. DOI: 10.1182/Blood-2019-131884 |
0.343 |
|
| 2019 |
Velazquez J, Sengal A, Allen CE, Chakraborty R. Creating and Testing a CD207+ Langerhans Cell Histiocytosis-like Cell Line Blood. 134: 5399-5399. DOI: 10.1182/Blood-2019-130588 |
0.365 |
|
| 2019 |
Chakraborty R, Velasquez J, Sengal A, Das A, Kode V, Mandloi N, Merad M, Allen CE. TCR Repertoire Clonality Analysis and Transcriptome Analyses of Immune Infiltrates in Patients with Langerhans Cell Histiocytosis Can Define Prognostic Biomarkers for Future Therapeutic Development Blood. 134: 3601-3601. DOI: 10.1182/Blood-2019-129013 |
0.38 |
|
| 2019 |
Sengal A, Hahne M, Velasquez J, Abhyankar H, Burke T, Olea W, Reyes R, Scull B, Bigenwald C, Bollard CM, Yu W, Merad M, McClain KL, Allen CE, Chakraborty R. Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCH Blood. 134: 3602-3602. DOI: 10.1182/Blood-2019-128253 |
0.358 |
|
| 2019 |
Agrusa J, Abdel Fattah EA, Lin H, Chakraborty R, Scull B, Abhyankar H, Ozuah NW, Eckstein OS, Horton TM, Kamdar K, McClain KL, Man CT, Allen CE. Comprehensive Cell Specific Transcriptome Profiling of a Pediatric Hodgkin Lymphoma Cohort Blood. 134: 2773-2773. DOI: 10.1182/Blood-2019-125982 |
0.36 |
|
| 2018 |
Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. The New England Journal of Medicine. 379: 856-868. PMID 30157397 DOI: 10.1056/Nejmra1607548 |
0.323 |
|
| 2018 |
Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. PMID 29720485 DOI: 10.1182/Blood-2018-03-839753 |
0.311 |
|
| 2018 |
Chinn IK, Eckstein OS, Peckham-Gregory EC, Goldberg BR, Forbes LR, Nicholas SK, Mace EM, Vogel TP, Abhyankar HA, Diaz MI, Heslop HE, Krance RA, Martinez CA, Nguyen TC, Bashir DA, ... ... Allen CE, et al. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. PMID 29632024 DOI: 10.1182/Blood-2017-11-814244 |
0.346 |
|
| 2018 |
Eckstein OS, Zinn D, Fein Levy C, Henry MM, Campbell P, Jordan MB, Kumar AR, Rodriguez-Galindo C, Hijiya N, Abla O, McClain KL, Allen CE. Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors Blood. 132: 3684-3684. DOI: 10.1182/Blood-2018-99-120393 |
0.379 |
|
| 2018 |
Peckham-Gregory E, Scheurer M, Chakraborty R, Abhyankar H, McClain KL, Allen CE, Lupo PJ. Inherited Genetic Risk Factors and Langerhans Cell Histiocytosis Relapse Events Blood. 132: 4278-4278. DOI: 10.1182/Blood-2018-99-118743 |
0.334 |
|
| 2018 |
Palmos DM, Chakraborty R, Abhyankar H, Jayaseelan JC, Cardenas MF, Kambugu J, Otiti J, Geriga F, Pala P, Sekabira J, Wasswa P, Ssenyondwa J, Orem J, Wheeler DA, Lubega J, ... Allen CE, et al. Whole Exome Analysis Reveals Key Genomic Differences between Sporadic and Endemic Pediatric Burkitt Lymphoma Blood. 132: 4117-4117. DOI: 10.1182/Blood-2018-99-110762 |
0.318 |
|
| 2017 |
Hogstad B, Berres ML, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, Lim KPH, Lin H, Man TK, Remark R, Baxter S, Kana V, Jordan S, Karoulia Z, Kwan WH, ... ... Allen CE, et al. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. The Journal of Experimental Medicine. PMID 29263218 DOI: 10.1084/Jem.20161881 |
0.335 |
|
| 2017 |
Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL. Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas. Pediatric Blood & Cancer. PMID 28944988 DOI: 10.1002/Pbc.26784 |
0.303 |
|
| 2017 |
Héritier S, Hélias-Rodzewicz Z, Chakraborty R, Sengal AG, Bellanné-Chantelot C, Thomas C, Moreau A, Fraitag S, Allen CE, Donadieu J, Emile JF. New somatic BRAF splicing mutation in Langerhans cell histiocytosis. Molecular Cancer. 16: 115. PMID 28679432 DOI: 10.1186/S12943-017-0690-Z |
0.32 |
|
| 2017 |
Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. PMID 28621800 DOI: 10.1002/Cncr.30826 |
0.303 |
|
| 2017 |
McNally JP, Millen SH, Chaturvedi V, Lakes N, Terrell CE, Elfers EE, Carroll KR, Hogan SP, Andreassen PR, Kanter J, Allen CE, Henry MM, Greenberg JN, Ladisch S, Hermiston ML, et al. Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases. Proceedings of the National Academy of Sciences of the United States of America. PMID 28533414 DOI: 10.1073/Pnas.1703683114 |
0.334 |
|
| 2017 |
Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults. Blood. PMID 28512190 DOI: 10.1182/Blood-2016-12-757823 |
0.358 |
|
| 2017 |
Lim KPH, Milne P, Poidinger M, Duan K, Lin H, Abhyankar H, Zinn D, Eckstein OS, Chakraborty R, Newell E, Merad M, McClain KL, Man CT, Ginhoux F, Collin MP, ... Allen CE, et al. Transcriptional Profiles, Lineage Tracing with BRAF-V600E and HLA-DQB2 Expression Support a Model of Blood CD1c+ Cells As Precursors to LCH Lesion CD207+ Cells Blood. 130: 4218-4218. DOI: 10.1182/Blood.V130.Suppl_1.4218.4218 |
0.342 |
|
| 2017 |
Zinn D, Picarsic J, Chakraborty R, Lin H, Abhyankar H, Scull B, Shih A, Lim KPH, Eckstein OS, Peters TL, Olea W, Burke T, Ahmed N, Hicks J, Tran B, ... ... Allen CE, et al. BRAF-V600E in Peripheral Mononuclear Cells and Microglia-like Brain Cells Suggest Hematopoietic Origin of Langerhans Cell Histiocytosis-Associated Neurodegeneration Blood. 130: 2930-2930. DOI: 10.1182/Blood.V130.Suppl_1.2930.2930 |
0.374 |
|
| 2017 |
Chakraborty R, Allen CE, Sengal A, Gaikwad AS, Abhyankar H, Scull B, Eckstein OS, Merad M, McClain KL. Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis Blood. 130: 2280-2280. DOI: 10.1182/Blood.V130.Suppl_1.2280.2280 |
0.376 |
|
| 2016 |
Arceci RJ, Allen CE, Dunkel IJ, Jacobsen E, Whitlock J, Vassallo R, Morris SR, Portnoy A, Reedy BA, Smith DA, Noble R, Murnane A, Cornfeld M, Rodriguez-Galindo C, Heaney ML, et al. A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis. Pediatric Blood & Cancer. PMID 27804235 DOI: 10.1002/Pbc.26325 |
0.327 |
|
| 2016 |
Chakraborty R, Burke TM, Hampton OA, Zinn DJ, Lim KP, Abhyankar H, Scull B, Kumar V, Kakkar N, Wheeler DA, Roy A, Poulikakos PI, Merad M, McClain KL, Parsons DW, ... Allen CE, et al. Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood. PMID 27729324 DOI: 10.1182/Blood-2016-08-733790 |
0.363 |
|
| 2016 |
Zinn DJ, Grimes AB, Lin H, Eckstein O, Allen CE, McClain KL. Hydroxyurea: a new old therapy for Langerhans cell histiocytosis. Blood. PMID 27688802 DOI: 10.1182/Blood-2016-06-721993 |
0.315 |
|
| 2016 |
Allen CE. ALPS DNT cells: active senior living with mTOR. Blood. 128: 152. PMID 27418624 DOI: 10.1182/Blood-2016-05-713032 |
0.331 |
|
| 2016 |
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Gil Herrera J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. PMID 26966089 DOI: 10.1182/Blood-2016-01-690636 |
0.322 |
|
| 2016 |
Chakraborty R, Sengal AG, Hahne M, Gaikwad AS, Scull B, Abhyankar H, Merad M, McClain K, Allen CE. Clonal, Exhausted and Activated Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis Lesions Blood. 128: 3708-3708. DOI: 10.1182/Blood.V128.22.3708.3708 |
0.372 |
|
| 2016 |
Rafiei A, Saito Y, Soldini D, Merad M, Allen CE, Manz MG. BRAFV600E Transduced Human CD34+ Cells Establish Aggressive Langerhans Cell Histiocytosis in Humanized Mice Blood. 128: 2739-2739. DOI: 10.1182/Blood.V128.22.2739.2739 |
0.356 |
|
| 2016 |
Eckstein OS, Bingham R, Peckham EC, Brown A, Allen CE, McClain KL. Efficacy and Toxicity Profile of Clofarabine in Patients with Recurrent/Refractory Langerhans Cell Histiocytosis and Other Histiocytic Disorders Blood. 128: 1329-1329. DOI: 10.1182/Blood.V128.22.1329.1329 |
0.324 |
|
| 2015 |
Allen CE, Parsons DW. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2015: 559-64. PMID 26637772 DOI: 10.1182/Asheducation-2015.1.559 |
0.335 |
|
| 2015 |
Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2015: 177-82. PMID 26637718 DOI: 10.1182/Asheducation-2015.1.177 |
0.338 |
|
| 2015 |
Collin M, Bigley V, McClain KL, Allen CE. Cell(s) of Origin of Langerhans Cell Histiocytosis. Hematology/Oncology Clinics of North America. 29: 825-38. PMID 26461145 DOI: 10.1016/J.Hoc.2015.06.003 |
0.368 |
|
| 2015 |
Allen CE, Ladisch S, McClain KL. How I treat Langerhans cell histiocytosis. Blood. 126: 26-35. PMID 25827831 DOI: 10.1182/Blood-2014-12-569301 |
0.382 |
|
| 2015 |
Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? British Journal of Haematology. 169: 3-13. PMID 25430560 DOI: 10.1111/Bjh.13247 |
0.373 |
|
| 2015 |
Prof FL, Allen C, Benedetti FD, Grom AA, Ballabio M, Ferlin WG, Min CD. A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH Blood. 126. DOI: 10.1182/Blood.V126.23.Lba-3.Lba-3 |
0.318 |
|
| 2015 |
Bhar S, Yassine K, Martinez C, Sasa GS, Naik S, Mahoney D, Bertuch AA, Allen C, Ahmed N, Hegde MG, Heslop HE, Brenner MK, Gottschalk S, Krance RA, Leung KS. Matched Unrelated Allogeneic Stem Cell Transplantation for Patients with Congenital Amegakaryocytic Thrombocytopenia: Texas Children`s Hospital Experience Blood. 126: 5529-5529. DOI: 10.1182/Blood.V126.23.5529.5529 |
0.325 |
|
| 2015 |
Zinn D, Lin H, Shih A, Scull B, Cantu MD, Abhyankar H, Chakraborty R, Lim KPH, Peters TL, Lira S, Tsz-Kwong C, McClain K, Merad M, Allen C. Inflammatory Plasma Proteins Predict Disease Severity and Response to Therapy in Patients with LCH Blood. 126: 4072-4072. DOI: 10.1182/Blood.V126.23.4072.4072 |
0.352 |
|
| 2015 |
Peckham E, Lupo PJ, Scheurer ME, Chakraborty R, Belmont J, Tsavachidis S, Shih A, Abhyankar H, Phaik Har Lim K, Scull B, McClain KL, Allen C. A Genome-Wide Assessment of Inherited Genetic Variants and the Risk of Langerhans Cell Histiocytosis Blood. 126: 4059-4059. DOI: 10.1182/Blood.V126.23.4059.4059 |
0.305 |
|
| 2015 |
Grimes AB, Zinn D, Eckstein OS, Allen C, McClain K. Hydroxyurea for the Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis Blood. 126: 1624-1624. DOI: 10.1182/Blood.V126.23.1624.1624 |
0.341 |
|
| 2014 |
Chakraborty R, Hampton OA, Shen X, Simko SJ, Shih A, Abhyankar H, Lim KP, Covington KR, Trevino L, Dewal N, Muzny DM, Doddapaneni H, Hu J, Wang L, Lupo PJ, ... ... Allen CE, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 124: 3007-15. PMID 25202140 DOI: 10.1182/Blood-2014-05-577825 |
0.328 |
|
| 2014 |
Papadopoulou A, Krance RA, Allen CE, Lee D, Rooney CM, Brenner MK, Leen AM, Heslop HE. Systemic inflammatory response syndrome after administration of unmodified T lymphocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1134-8. PMID 24651135 DOI: 10.1038/Mt.2014.48 |
0.308 |
|
| 2014 |
Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, ... ... Allen CE, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine. 211: 669-83. PMID 24638167 DOI: 10.1084/Jem.20130977 |
0.333 |
|
| 2014 |
Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegón F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, ... ... Allen CE, et al. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatric Blood & Cancer. 61: 479-87. PMID 24106153 DOI: 10.1002/Pbc.24772 |
0.317 |
|
| 2014 |
Simko SJ, Berres M, Lim KP, Peters T, Price J, Lupo PJ, Hicks MJ, Shih A, Heym K, McClain KL, Merad M, Sarabia S, Lopez-Terrada D, Allen CE. Abstract B79: Detectable BRAF-V600E mutation in circulating peripheral blood of patients with Langerhans cell histiocytosis correlates with risk organ involvement and residual disease Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B79 |
0.358 |
|
| 2013 |
Berres ML, Allen CE, Merad M. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Advances in Immunology. 120: 127-61. PMID 24070383 DOI: 10.1016/B978-0-12-417028-5.00005-3 |
0.342 |
|
| 2013 |
Arceci RJ, Allen CE, Dunkel I, Jacobsen ED, Whitlock J, Vassallo R, Borrello IM, Oliff A, Morris SR, Ann M Reedy B, Portnoy A, Smith DA, Noble B, Murnane AA, Szabo SA, et al. Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis Blood. 122: 2907-2907. DOI: 10.1182/Blood.V122.21.2907.2907 |
0.325 |
|
| 2013 |
Cantu MD, Peters TL, Phaik-Har Lim K, Shih A, Chakraborty R, Abhyankar H, Cantu MA, McClain K, Chris Man T, Allen CE. Plasma Biomarker Profiling In Langerhans Cell Histiocytosis: Risk-Stratifying The Inflammatory Storm Blood. 122: 2854-2854. DOI: 10.1182/Blood.V122.21.2854.2854 |
0.321 |
|
| 2013 |
Phaik-Har Lim K, Peters TL, Berres M, Price J, Takizawa H, Lupo P, Hicks MJ, Shih A, Simko SJ, Heym KM, Bigley V, Collin MP, Manz MG, McClain K, Merad M, ... Allen CE, et al. Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia Blood. 122: 103-103. DOI: 10.1182/Blood.V122.21.103.103 |
0.375 |
|
| 2012 |
Allen CE. Langerhans Cell Histiocytosis: Back to Histiocytosis X Blood. 120: SCI-8-SCI-8. DOI: 10.1182/Blood.V120.21.Sci-8.Sci-8 |
0.375 |
|
| 2012 |
Peters T, Lim PH, Hicks MJ, McClain KL, Allen CE. The Effect of BRAF V600E Mutation in the CD207+ Cell of Langerhans Cell Histiocytosis on the Clinical Presentation and the Transcriptome American Journal of Clinical Pathology. 138: A220-A220. DOI: 10.1093/Ajcp/138.Suppl2.112 |
0.318 |
|
| 2011 |
Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 118: 4041-52. PMID 21828139 DOI: 10.1182/Blood-2011-03-278127 |
0.3 |
|
| 2011 |
Liu S, Madiai F, Hackshaw KV, Allen CE, Carl J, Huschart E, Karanfilov C, Litsky A, Hickey CJ, Marcucci G, Huja S, Agarwal S, Yu J, Caligiuri MA, Wu LC. The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis. Plos One. 6: e17161. PMID 21390242 DOI: 10.1371/Journal.Pone.0017161 |
0.499 |
|
| 2011 |
Yakovich AJ, Jiang B, Allen CE, Du J, Wu LC, Barnard JA. ZAS3 accentuates transforming growth factor β signaling in epithelial cells. Cellular Signalling. 23: 105-13. PMID 20732416 DOI: 10.1016/J.Cellsig.2010.08.009 |
0.548 |
|
| 2011 |
Peters TL, Man TC, Price J, George R, Lim PH, Heym KM, Merad M, McClain KL, Allen CE. Frequent BRAF V600E Mutations Are Identified in CD207+ Cells in LCH Lesions, but BRAF Status does not Correlate with Clinical Presentation of Patients or Transcriptional Profiles of CD207+ Cells Blood. 118: 1372-1372. DOI: 10.1182/Blood.V118.21.1372.1372 |
0.344 |
|
| 2010 |
Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, Merad M, McClain KL. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 4557-67. PMID 20220088 DOI: 10.4049/Jimmunol.0902336 |
0.37 |
|
| 2009 |
Allen CE, McClain KL. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nature Medicine. 15: 483-4; author reply . PMID 19424201 DOI: 10.1038/Nm0509-483 |
0.304 |
|
| 2007 |
Allen CE, Richards J, Muthusamy N, Auer H, Liu Y, Robinson ML, Barnard JA, Wu LC. Disruption of ZAS3 in mice alters NF-kappaB and AP-1 DNA binding and T-cell development. Gene Expression. 14: 83-100. PMID 18257392 DOI: 10.3727/105221607783417574 |
0.564 |
|
| 2007 |
Allen CE, McClain KL. Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs of Today (Barcelona, Spain : 1998). 43: 627-43. PMID 17940639 DOI: 10.1358/Dot.2007.43.9.1088823 |
0.33 |
|
| 2003 |
Hong JW, Allen CE, Wu LC. Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motif. Proceedings of the National Academy of Sciences of the United States of America. 100: 12301-6. PMID 14530385 DOI: 10.1073/Pnas.2133048100 |
0.657 |
|
| 2002 |
Allen CE, Muthusamy N, Weisbrode SE, Hong JW, Wu LC. Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC. Genes, Chromosomes & Cancer. 35: 287-98. PMID 12378523 DOI: 10.1002/Gcc.10128 |
0.676 |
|
| 2002 |
Allen CE, Mak CH, Wu LC. The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study. Bmc Immunology. 3: 10. PMID 12193271 DOI: 10.1186/1471-2172-3-10 |
0.527 |
|
| 2001 |
Wu LC, Hicar MD, Hong J, Allen CE. The DNA-binding ability of HIVEP3/KRC decreases upon activation of V(D)J recombination. Immunogenetics. 53: 564-71. PMID 11685469 DOI: 10.1007/S002510100360 |
0.736 |
|
| 2001 |
Hicar MD, Liu Y, Allen CE, Wu LC. Structure of the human zinc finger protein HIVEP3: molecular cloning, expression, exon-intron structure, and comparison with paralogous genes HIVEP1 and HIVEP2. Genomics. 71: 89-100. PMID 11161801 DOI: 10.1006/Geno.2000.6425 |
0.705 |
|
| 2000 |
Allen CE, Wu LC. Downregulation of KRC induces proliferation, anchorage independence, and mitotic cell death in HeLa cells. Experimental Cell Research. 260: 346-56. PMID 11035930 DOI: 10.1006/Excr.2000.5029 |
0.552 |
|
| 2000 |
Hjelmsoe I, Allen CE, Cohn MA, Tulchinsky EM, Wu LC. The kappaB and V(D)J recombination signal sequence binding protein KRC regulates transcription of the mouse metastasis-associated gene S100A4/mts1. The Journal of Biological Chemistry. 275: 913-20. PMID 10625627 DOI: 10.1074/Jbc.275.2.913 |
0.556 |
|
| 1998 |
Mak CH, Li Z, Allen CE, Liu Y, Wu LC. KRC transcripts: Identification of an unusual alternative splicing event Immunogenetics. 48: 32-39. PMID 9601941 DOI: 10.1007/S002510050397 |
0.324 |
|
| Show low-probability matches. |